Buys
Open market- Shares
- Avg price
- Total value
Ph.D Frank Yocca - Chief Scientific Officer at BioXcel Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- BTAI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Ph.D Frank Yocca in BioXcel Therapeutics, Inc.
Sells
Open market- Shares
- -6,845
- Avg price
- $1.08
- Total value
- -$7,427
Net
Past year- Shares
- -6,845
- Share %
- -100%
- Total value
- -$7,427
Reported holdings for Ph.D Frank Yocca in BioXcel Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer
BioXcel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 26,210
- Estimated value
- $35,121
- Report date
- 15 Jun 2026
- Price
- $1.34
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer
BioXcel Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 212
- Estimated value
- $136
- Report date
- 15 Jun 2026
- Price
- $0.3523
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ph.D Frank Yocca in BioXcel Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.